{"transactions":[{"id":2084294,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2022-12-17T01:09:47.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020."}],"balance_after":20000,"derivative":{"exercise_price":4.2,"exercise_date":"2017-02-11","expiration_date":"2023-02-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000939767-22-000122","document":"wf-form4_167123936903484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000122/wf-form4_167123936903484.xml","form_type":"4"}},{"id":2084293,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-12-17T01:09:47.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":20000,"price":15.88,"value":317600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.71 to $16.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":410958,"source":{"system":"sec-edgar","filing":"0000939767-22-000122","document":"wf-form4_167123936903484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000122/wf-form4_167123936903484.xml","form_type":"4"}},{"id":2084292,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-12-17T01:09:47.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":20000,"price":4.2,"value":84000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 120,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":430958,"source":{"system":"sec-edgar","filing":"0000939767-22-000122","document":"wf-form4_167123936903484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000122/wf-form4_167123936903484.xml","form_type":"4"}},{"id":2113071,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-11-18T01:42:32.000Z","date":"2022-11-15","kind":"tax_withholding","acquired":false,"shares":7177,"price":16.71,"value":119927.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 11, 2020, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on September 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":410958,"source":{"system":"sec-edgar","filing":"0000939767-22-000113","document":"wf-form4_166873573294104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000113/wf-form4_166873573294104.xml","form_type":"4"}},{"id":2193792,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-08-06T01:45:57.000Z","date":"2022-08-03","kind":"tax_withholding","acquired":false,"shares":7177,"price":21.49,"value":154233.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on August 3, 2022."}],"balance_after":418135,"source":{"system":"sec-edgar","filing":"0000939767-22-000087","document":"wf-form4_165975033940250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000087/wf-form4_165975033940250.xml","form_type":"4"}},{"id":2193791,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-08-06T01:45:57.000Z","date":"2022-08-03","kind":"grant","acquired":true,"shares":28950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 11, 2020, the Reporting Person was granted a performance-based restricted stock unit award (\"PSU\") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 57,900 shares of common stock (such shares, the \"Target Shares\"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement of certain performance criteria as certified by the Compensation Committee (the \"Committee\"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU."},{"field":"shares","element":"transactionShares","label":"F3","text":"On August 3, 2022, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 50% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and 25% of the Target Shares will vest on August 15, 2023, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 134,858 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":425312,"source":{"system":"sec-edgar","filing":"0000939767-22-000087","document":"wf-form4_165975033940250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000087/wf-form4_165975033940250.xml","form_type":"4"}},{"id":2268971,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-05-18T00:22:13.000Z","date":"2022-05-15","kind":"tax_withholding","acquired":false,"shares":6123,"price":20.08,"value":122949.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded March 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":396362,"source":{"system":"sec-edgar","filing":"0000939767-22-000061","document":"wf-form4_165283331491227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000061/wf-form4_165283331491227.xml","form_type":"4"}},{"id":2345509,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-03-09T01:52:22.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":59490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2023 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 132,731 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":402485,"source":{"system":"sec-edgar","filing":"0000939767-22-000035","document":"wf-form4_164679071956142.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000035/wf-form4_164679071956142.xml","form_type":"4"}},{"id":2389645,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-02-18T01:09:30.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":17651,"price":18.59,"value":328132.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021."}],"balance_after":342995,"source":{"system":"sec-edgar","filing":"0000939767-22-000021","document":"wf-form4_164514655521783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000021/wf-form4_164514655521783.xml","form_type":"4"}},{"id":2389644,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2022-02-18T01:09:30.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":2526,"price":18.59,"value":46958.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,241 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":360646,"source":{"system":"sec-edgar","filing":"0000939767-22-000021","document":"wf-form4_164514655521783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000021/wf-form4_164514655521783.xml","form_type":"4"}},{"id":2468427,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-12-18T01:35:18.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option, representing the right to purchase a total of 190,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019."}],"balance_after":0,"derivative":{"exercise_price":6.21,"exercise_date":"2016-09-16","expiration_date":"2022-09-15","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000939767-21-000115","document":"wf-form4_163979129617804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000115/wf-form4_163979129617804.xml","form_type":"4"}},{"id":2468426,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-12-18T01:35:18.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":47500,"price":17.44,"value":828400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.95 to $17.86. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 7 to this Form 4."}],"balance_after":363172,"source":{"system":"sec-edgar","filing":"0000939767-21-000115","document":"wf-form4_163979129617804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000115/wf-form4_163979129617804.xml","form_type":"4"}},{"id":2468425,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-12-18T01:35:18.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":47500,"price":6.21,"value":294975.0,"ownership":{"direct":true},"balance_after":410672,"source":{"system":"sec-edgar","filing":"0000939767-21-000115","document":"wf-form4_163979129617804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000115/wf-form4_163979129617804.xml","form_type":"4"}},{"id":2468424,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-12-18T01:35:18.000Z","date":"2021-12-15","kind":"tax_withholding","acquired":false,"shares":4646,"price":17,"value":78982.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on December 15, 2021."}],"balance_after":363172,"source":{"system":"sec-edgar","filing":"0000939767-21-000115","document":"wf-form4_163979129617804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000115/wf-form4_163979129617804.xml","form_type":"4"}},{"id":2468423,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-12-18T01:35:18.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":18741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock  issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 18,741 shares of common stock. The PSU award generally vests as follows: (i) 50% of the original number of shares subject to the award vest upon certification by the Compensation Committee (the \"Committee\") that Exelixis, Inc. has achieved certain performance criteria related to the submission of Investigational New Drug applications with the U.S. Food and Drug Administration, or equivalent applications or filings with a foreign governmental authority, with respect to product candidates discovered, in-licensed or acquired by Exelixis, Inc. (the \"2018 PSU Goal\"); and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On December 15, 2021, the Committee convened to determine that the 2018 PSU Goal had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on February 15, 2023, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 113,573 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":367818,"source":{"system":"sec-edgar","filing":"0000939767-21-000115","document":"wf-form4_163979129617804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000115/wf-form4_163979129617804.xml","form_type":"4"}},{"id":2508727,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-11-18T01:02:39.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option, representing the right to purchase a total of 190,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019."}],"balance_after":47500,"derivative":{"exercise_price":6.21,"exercise_date":"2016-09-16","expiration_date":"2022-09-15","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000939767-21-000100","document":"wf-form4_163719731783522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000100/wf-form4_163719731783522.xml","form_type":"4"}},{"id":2508726,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T01:02:39.000Z","date":"2021-11-15","kind":"tax_withholding","acquired":false,"shares":53022,"price":18.1,"value":959698.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on October 22, 2020."}],"balance_after":349077,"source":{"system":"sec-edgar","filing":"0000939767-21-000100","document":"wf-form4_163719731783522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000100/wf-form4_163719731783522.xml","form_type":"4"}},{"id":2508725,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T01:02:39.000Z","date":"2021-11-15","kind":"tax_withholding","acquired":false,"shares":2323,"price":18.1,"value":42046.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 2, 2020."}],"balance_after":402099,"source":{"system":"sec-edgar","filing":"0000939767-21-000100","document":"wf-form4_163719731783522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000100/wf-form4_163719731783522.xml","form_type":"4"}},{"id":2508724,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T01:02:39.000Z","date":"2021-11-15","kind":"tax_withholding","acquired":false,"shares":6818,"price":18.1,"value":123405.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017."}],"balance_after":404422,"source":{"system":"sec-edgar","filing":"0000939767-21-000100","document":"wf-form4_163719731783522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000100/wf-form4_163719731783522.xml","form_type":"4"}},{"id":2508723,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T01:02:39.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":47500,"price":18.09,"value":859275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.94 to $18.28. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":411240,"source":{"system":"sec-edgar","filing":"0000939767-21-000100","document":"wf-form4_163719731783522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000100/wf-form4_163719731783522.xml","form_type":"4"}},{"id":2508722,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T01:02:39.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":47500,"price":6.21,"value":294975.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104,202 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":458740,"source":{"system":"sec-edgar","filing":"0000939767-21-000100","document":"wf-form4_163719731783522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000100/wf-form4_163719731783522.xml","form_type":"4"}},{"id":2541956,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-10-16T00:15:39.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 190,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019."}],"balance_after":95000,"derivative":{"exercise_price":6.21,"exercise_date":"2016-09-16","expiration_date":"2022-09-15","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000939767-21-000089","document":"wf-form4_163434332005821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000089/wf-form4_163434332005821.xml","form_type":"4"}},{"id":2541955,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-10-16T00:15:39.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":47500,"price":21.92,"value":1041200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.69 to $22.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":411240,"source":{"system":"sec-edgar","filing":"0000939767-21-000089","document":"wf-form4_163434332005821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000089/wf-form4_163434332005821.xml","form_type":"4"}},{"id":2541954,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-10-16T00:15:39.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":47500,"price":6.21,"value":294975.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 229,577 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":458740,"source":{"system":"sec-edgar","filing":"0000939767-21-000089","document":"wf-form4_163434332005821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000089/wf-form4_163434332005821.xml","form_type":"4"}},{"id":2552932,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-10-05T00:02:50.000Z","date":"2021-09-30","kind":"tax_withholding","acquired":false,"shares":7177,"price":20.63,"value":148061.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 30, 2021."}],"balance_after":411240,"source":{"system":"sec-edgar","filing":"0000939767-21-000084","document":"wf-form4_163339215355376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000084/wf-form4_163339215355376.xml","form_type":"4"}},{"id":2552931,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-10-05T00:02:50.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":28950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 11, 2020, the Reporting Person was granted a performance-based restricted stock unit award (\"PSU\") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 57,900 shares of common stock (such shares, the \"Target Shares\"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon certification by the Compensation Committee (the \"Committee\") that Exelixis has achieved certain performance criteria; and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU."},{"field":"shares","element":"transactionShares","label":"F3","text":"On September 30, 2021, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 50% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and 25% of the Target Shares will vest on November 15, 2022, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 229,577 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":418417,"source":{"system":"sec-edgar","filing":"0000939767-21-000084","document":"wf-form4_163339215355376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000084/wf-form4_163339215355376.xml","form_type":"4"}},{"id":2566656,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-09-17T23:56:23.000Z","date":"2021-09-15","kind":"exercise","acquired":false,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 190,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019."}],"balance_after":142500,"derivative":{"exercise_price":6.21,"exercise_date":"2016-09-16","expiration_date":"2022-09-15","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000939767-21-000081","document":"wf-form4_163192296573118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000081/wf-form4_163192296573118.xml","form_type":"4"}},{"id":2566655,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-09-17T23:56:23.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":47500,"price":20.46,"value":971850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.62. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":389467,"source":{"system":"sec-edgar","filing":"0000939767-21-000081","document":"wf-form4_163192296573118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000081/wf-form4_163192296573118.xml","form_type":"4"}},{"id":2566654,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-09-17T23:56:23.000Z","date":"2021-09-15","kind":"exercise","acquired":true,"shares":47500,"price":6.21,"value":294975.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":436967,"source":{"system":"sec-edgar","filing":"0000939767-21-000081","document":"wf-form4_163192296573118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000081/wf-form4_163192296573118.xml","form_type":"4"}},{"id":2598676,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-08-18T23:56:57.000Z","date":"2021-08-16","kind":"exercise","acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 175,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.9,"exercise_date":"2015-07-20","expiration_date":"2022-02-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000939767-21-000079","document":"wf-form4_162933099603526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000079/wf-form4_162933099603526.xml","form_type":"4"}},{"id":2598675,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-08-18T23:56:57.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":55000,"price":18.44,"value":1014200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.22 to $18.65. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":389467,"source":{"system":"sec-edgar","filing":"0000939767-21-000079","document":"wf-form4_162933099603526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000079/wf-form4_162933099603526.xml","form_type":"4"}},{"id":2598674,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-08-18T23:56:57.000Z","date":"2021-08-16","kind":"exercise","acquired":true,"shares":55000,"price":1.9,"value":104500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":444467,"source":{"system":"sec-edgar","filing":"0000939767-21-000079","document":"wf-form4_162933099603526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000079/wf-form4_162933099603526.xml","form_type":"4"}},{"id":2632488,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-07-16T23:58:51.000Z","date":"2021-07-15","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 175,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":55000,"derivative":{"exercise_price":1.9,"exercise_date":"2015-07-20","expiration_date":"2022-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000939767-21-000072","document":"wf-form4_162647991700323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000072/wf-form4_162647991700323.xml","form_type":"4"}},{"id":2632487,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-07-16T23:58:51.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":60000,"price":17.47,"value":1048200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.22 to $17.63. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":389467,"source":{"system":"sec-edgar","filing":"0000939767-21-000072","document":"wf-form4_162647991700323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000072/wf-form4_162647991700323.xml","form_type":"4"}},{"id":2632486,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-07-16T23:58:51.000Z","date":"2021-07-15","kind":"exercise","acquired":true,"shares":60000,"price":1.9,"value":114000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":449467,"source":{"system":"sec-edgar","filing":"0000939767-21-000072","document":"wf-form4_162647991700323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000072/wf-form4_162647991700323.xml","form_type":"4"}},{"id":2659550,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-06-23T00:03:49.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 175,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":115000,"derivative":{"exercise_price":1.9,"exercise_date":"2015-07-20","expiration_date":"2022-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000939767-21-000070","document":"wf-form4_162440660264370.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000070/wf-form4_162440660264370.xml","form_type":"4"}},{"id":2659549,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-06-23T00:03:49.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":60000,"price":22.18,"value":1330800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.90 to $22.40. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":389467,"source":{"system":"sec-edgar","filing":"0000939767-21-000070","document":"wf-form4_162440660264370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000070/wf-form4_162440660264370.xml","form_type":"4"}},{"id":2659548,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-06-23T00:03:49.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":60000,"price":1.9,"value":114000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":449467,"source":{"system":"sec-edgar","filing":"0000939767-21-000070","document":"wf-form4_162440660264370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000070/wf-form4_162440660264370.xml","form_type":"4"}},{"id":2762477,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-04-02T23:51:28.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000939767-21-000040","document":"wf-form4_161740743547342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000040/wf-form4_161740743547342.xml","form_type":"4"}},{"id":2762476,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-04-02T23:51:28.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":60000,"price":22.96,"value":1377600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.58 to $23.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":389467,"source":{"system":"sec-edgar","filing":"0000939767-21-000040","document":"wf-form4_161740743547342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000040/wf-form4_161740743547342.xml","form_type":"4"}},{"id":2762475,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-04-02T23:51:28.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":60000,"price":1.7,"value":102000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":449467,"source":{"system":"sec-edgar","filing":"0000939767-21-000040","document":"wf-form4_161740743547342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000040/wf-form4_161740743547342.xml","form_type":"4"}},{"id":2807250,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-03-06T00:56:42.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":49395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2022 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 215,102 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":389467,"source":{"system":"sec-edgar","filing":"0000939767-21-000031","document":"wf-form4_161499218634349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000031/wf-form4_161499218634349.xml","form_type":"4"}},{"id":2816085,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-03-04T00:49:07.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":60000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000939767-21-000029","document":"wf-form4_161481892190996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000029/wf-form4_161481892190996.xml","form_type":"4"}},{"id":2816084,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-03-04T00:49:07.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":65000,"price":22.11,"value":1437150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.65 to $22.45. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":340072,"source":{"system":"sec-edgar","filing":"0000939767-21-000029","document":"wf-form4_161481892190996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000029/wf-form4_161481892190996.xml","form_type":"4"}},{"id":2816083,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-03-04T00:49:07.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":65000,"price":1.7,"value":110500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 165,707 be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":405072,"source":{"system":"sec-edgar","filing":"0000939767-21-000029","document":"wf-form4_161481892190996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000029/wf-form4_161481892190996.xml","form_type":"4"}},{"id":2856025,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-02-18T01:05:24.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":3718,"price":21.91,"value":81461.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on December 4, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 165,707 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":340072,"source":{"system":"sec-edgar","filing":"0000939767-21-000015","document":"wf-form4_161361029561533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000015/wf-form4_161361029561533.xml","form_type":"4"}},{"id":2877825,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-02-06T02:18:50.000Z","date":"2021-02-03","kind":"tax_withholding","acquired":false,"shares":19997,"price":22.56,"value":451132.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on February 3, 2021."}],"balance_after":343790,"source":{"system":"sec-edgar","filing":"0000939767-21-000012","document":"wf-form4_161257791484447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000012/wf-form4_161257791484447.xml","form_type":"4"}},{"id":2877824,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-02-06T02:18:50.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":71293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F5","text":"On September 20, 2019, the Reporting Person was granted a PSU award the under 2017 Equity Incentive Plan covering 142,586 shares of common stock (such award, the \"2019 Award,\" and such shares, the \"Target Shares\"). The 2019 Award generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by Committee; and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the 2019 Award provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the 2019 Award."},{"field":"shares","element":"transactionShares","label":"F6","text":"On February 3, 2021, the Committee determined the maximum performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 200% of the Target Shares subject to the 2019 Award. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and the remaining 25% of the Target Shares will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 173,204 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":363787,"source":{"system":"sec-edgar","filing":"0000939767-21-000012","document":"wf-form4_161257791484447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000012/wf-form4_161257791484447.xml","form_type":"4"}},{"id":2877823,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-02-06T02:18:50.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":9370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 9,370 shares of common stock (such award, the \"2018 Award\"). The 2018 Award generally vests as follows: (i) 50% of the original number of shares subject to the 2018 Award vest upon certification by the Compensation Committee (the \"Committee\") that Exelixis has achieved certain performance criteria related to clinical trial enrollment or positive top-line results (the \"2018 Goal\"); and (ii) 50% of the original number of shares subject to the 2018 Award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On February 3, 2021, the Committee convened to determine that the 2018 Goal had been achieved, resulting in the immediate vesting of 50% of the 2018 Award, and the remaining 50% will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 137,557 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":292494,"source":{"system":"sec-edgar","filing":"0000939767-21-000012","document":"wf-form4_161257791484447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000012/wf-form4_161257791484447.xml","form_type":"4"}},{"id":2883189,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-02-04T00:57:31.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":125000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000939767-21-000007","document":"wf-form4_161240023597689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000007/wf-form4_161240023597689.xml","form_type":"4"}},{"id":2883188,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-02-04T00:57:31.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":65000,"price":22.08,"value":1435200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.80 to $22.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":283124,"source":{"system":"sec-edgar","filing":"0000939767-21-000007","document":"wf-form4_161240023597689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000007/wf-form4_161240023597689.xml","form_type":"4"}},{"id":2883187,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-02-04T00:57:31.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":65000,"price":1.7,"value":110500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 132,872 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":348124,"source":{"system":"sec-edgar","filing":"0000939767-21-000007","document":"wf-form4_161240023597689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000007/wf-form4_161240023597689.xml","form_type":"4"}},{"id":2917086,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2021-01-07T01:40:50.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":190000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000939767-21-000002","document":"wf-form4_160998363690231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000002/wf-form4_160998363690231.xml","form_type":"4"}},{"id":2917085,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-01-07T01:40:50.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":65000,"price":20.32,"value":1320800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.87 to $20.55. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":283124,"source":{"system":"sec-edgar","filing":"0000939767-21-000002","document":"wf-form4_160998363690231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000002/wf-form4_160998363690231.xml","form_type":"4"}},{"id":2917084,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2021-01-07T01:40:50.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":65000,"price":1.7,"value":110500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 132,872 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":348124,"source":{"system":"sec-edgar","filing":"0000939767-21-000002","document":"wf-form4_160998363690231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000002/wf-form4_160998363690231.xml","form_type":"4"}},{"id":2935252,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2020-12-23T00:58:31.000Z","date":"2020-12-18","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":255000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000939767-20-000160","document":"wf-form4_160868509495790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000160/wf-form4_160868509495790.xml","form_type":"4"}},{"id":2935251,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-12-23T00:58:31.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":65000,"price":20.01,"value":1300650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.80 to $20.43. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":283124,"source":{"system":"sec-edgar","filing":"0000939767-20-000160","document":"wf-form4_160868509495790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000160/wf-form4_160868509495790.xml","form_type":"4"}},{"id":2935250,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-12-23T00:58:31.000Z","date":"2020-12-18","kind":"exercise","acquired":true,"shares":65000,"price":1.7,"value":110500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 132,872 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":348124,"source":{"system":"sec-edgar","filing":"0000939767-20-000160","document":"wf-form4_160868509495790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000160/wf-form4_160868509495790.xml","form_type":"4"}},{"id":2978421,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-11-18T01:06:20.000Z","date":"2020-11-15","kind":"tax_withholding","acquired":false,"shares":2014,"price":20.16,"value":40602.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 22, 2016."}],"balance_after":283124,"source":{"system":"sec-edgar","filing":"0000939767-20-000154","document":"wf-form4_160566156697034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000154/wf-form4_160566156697034.xml","form_type":"4"}},{"id":2978420,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-11-18T01:06:20.000Z","date":"2020-11-15","kind":"tax_withholding","acquired":false,"shares":6818,"price":20.16,"value":137450.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017."}],"balance_after":285138,"source":{"system":"sec-edgar","filing":"0000939767-20-000154","document":"wf-form4_160566156697034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000154/wf-form4_160566156697034.xml","form_type":"4"}},{"id":2978419,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-11-18T01:06:20.000Z","date":"2020-11-15","kind":"tax_withholding","acquired":false,"shares":2479,"price":20.16,"value":49976.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 12, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 132,872 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":291956,"source":{"system":"sec-edgar","filing":"0000939767-20-000154","document":"wf-form4_160566156697034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000154/wf-form4_160566156697034.xml","form_type":"4"}},{"id":3000189,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-10-26T23:57:33.000Z","date":"2020-10-22","kind":"tax_withholding","acquired":false,"shares":53022,"price":21.79,"value":1155349.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on October 22, 2020."}],"balance_after":294435,"source":{"system":"sec-edgar","filing":"0000939767-20-000136","document":"wf-form4_160375663763003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000136/wf-form4_160375663763003.xml","form_type":"4"}},{"id":3000188,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-10-26T23:57:33.000Z","date":"2020-10-22","kind":"grant","acquired":true,"shares":213879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 20, 2019, the Reporting Person was granted a performance-based restricted stock unit award (\"PSU\") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 142,586 shares of common stock (such shares, the \"Target Shares\"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by the Compensation Committee (the \"Committee\"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 22, 2020, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 150% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 75% of the Target Shares, and 75% of the Target Shares will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date.  The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 155,682 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":347457,"source":{"system":"sec-edgar","filing":"0000939767-20-000136","document":"wf-form4_160375663763003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000136/wf-form4_160375663763003.xml","form_type":"4"}},{"id":3038086,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-09-04T22:41:24.000Z","date":"2020-09-02","kind":"tax_withholding","acquired":false,"shares":2323,"price":21.58,"value":50130.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 2, 2020."}],"balance_after":133578,"source":{"system":"sec-edgar","filing":"0000939767-20-000127","document":"wf-form4_159925926667797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000127/wf-form4_159925926667797.xml","form_type":"4"}},{"id":3038085,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-09-04T22:41:24.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":9370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award of 9,370 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan. Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the \"Committee\") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that a target number of potentially label-enabling clinical trials evaluating cabozantinib (both alone or in combination with another therapy) have been initiated; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On September 2, 2020, the Committee convened to determine that the target number of clinical trial initiations had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 48,742 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":135901,"source":{"system":"sec-edgar","filing":"0000939767-20-000127","document":"wf-form4_159925926667797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000127/wf-form4_159925926667797.xml","form_type":"4"}},{"id":3115272,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2020-06-11T00:19:43.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 126,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000939767-20-000103","document":"wf-form4_159183476554219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000103/wf-form4_159183476554219.xml","form_type":"4"}},{"id":3115271,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-06-11T00:19:43.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":26000,"price":22.56,"value":586560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.28 to $22.81. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":126531,"source":{"system":"sec-edgar","filing":"0000939767-20-000103","document":"wf-form4_159183476554219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000103/wf-form4_159183476554219.xml","form_type":"4"}},{"id":3115270,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-06-11T00:19:43.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":26000,"price":5.51,"value":143260.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 44,057 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":152531,"source":{"system":"sec-edgar","filing":"0000939767-20-000103","document":"wf-form4_159183476554219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000103/wf-form4_159183476554219.xml","form_type":"4"}},{"id":3156981,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2020-05-09T01:11:47.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 126,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":26000,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-20-000070","document":"wf-form4_158898668578327.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000070/wf-form4_158898668578327.xml","form_type":"4"}},{"id":3156980,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-05-09T01:11:47.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":50000,"price":25.54,"value":1277000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.28 to $25.91. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":126531,"source":{"system":"sec-edgar","filing":"0000939767-20-000070","document":"wf-form4_158898668578327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000070/wf-form4_158898668578327.xml","form_type":"4"}},{"id":3156979,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-05-09T01:11:47.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 44,057 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":176531,"source":{"system":"sec-edgar","filing":"0000939767-20-000070","document":"wf-form4_158898668578327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000070/wf-form4_158898668578327.xml","form_type":"4"}},{"id":3180006,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2020-04-09T00:12:53.000Z","date":"2020-04-06","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 126,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":76000,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-20-000047","document":"wf-form4_158639115453049.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000047/wf-form4_158639115453049.xml","form_type":"4"}},{"id":3180005,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-04-09T00:12:53.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":50000,"price":17.26,"value":863000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.76 to $17.66. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":126531,"source":{"system":"sec-edgar","filing":"0000939767-20-000047","document":"wf-form4_158639115453049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000047/wf-form4_158639115453049.xml","form_type":"4"}},{"id":3180004,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2020-04-09T00:12:53.000Z","date":"2020-04-06","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 44,057 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":176531,"source":{"system":"sec-edgar","filing":"0000939767-20-000047","document":"wf-form4_158639115453049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000047/wf-form4_158639115453049.xml","form_type":"4"}},{"id":3350186,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-12-07T00:18:43.000Z","date":"2019-12-04","kind":"tax_withholding","acquired":false,"shares":3872,"price":17.67,"value":68418.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on December 4, 2019."}],"balance_after":126531,"source":{"system":"sec-edgar","filing":"0000939767-19-000202","document":"wf-form4_157567790413403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000202/wf-form4_157567790413403.xml","form_type":"4"}},{"id":3350185,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-12-07T00:18:43.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":14993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award of 14,993  shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan.  Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the \"Committee\") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that Exelixis, Inc. has achieved a net product revenue target over four consecutive fiscal quarters; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On December 4, 2019, the Committee convened to determine that the net product revenue target over four consecutive fiscal quarters had been achieved during the three months ended September 27, 2019, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on February 15, 2021, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 44,057 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":130403,"source":{"system":"sec-edgar","filing":"0000939767-19-000202","document":"wf-form4_157567790413403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000202/wf-form4_157567790413403.xml","form_type":"4"}},{"id":3370434,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-11-16T02:37:21.000Z","date":"2019-11-15","kind":"tax_withholding","acquired":false,"shares":2099,"price":16.51,"value":34654.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016."}],"balance_after":115410,"source":{"system":"sec-edgar","filing":"0000939767-19-000195","document":"wf-form4_157387182493703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000195/wf-form4_157387182493703.xml","form_type":"4"}},{"id":3370433,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-11-16T02:37:21.000Z","date":"2019-11-15","kind":"tax_withholding","acquired":false,"shares":7102,"price":16.51,"value":117254.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 36,560 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":117509,"source":{"system":"sec-edgar","filing":"0000939767-19-000195","document":"wf-form4_157387182493703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000195/wf-form4_157387182493703.xml","form_type":"4"}},{"id":3415335,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-09-14T00:47:23.000Z","date":"2019-09-12","kind":"tax_withholding","acquired":false,"shares":2581,"price":19.26,"value":49710.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 12, 2019."}],"balance_after":124611,"source":{"system":"sec-edgar","filing":"0000939767-19-000172","document":"wf-form4_156842202463551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000172/wf-form4_156842202463551.xml","form_type":"4"}},{"id":3415334,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-09-14T00:47:23.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":9995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award of 9,995 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan.  Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the \"Committee\") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Compensation Committee's certification that Exelixis, Inc. has achieved a quarterly net product revenue target; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On September 12, 2019, the Committee convened to determine that the quarterly net product revenue target had been achieved during the three months ended June 28, 2019, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2020, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 54,372 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":127192,"source":{"system":"sec-edgar","filing":"0000939767-19-000172","document":"wf-form4_156842202463551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000172/wf-form4_156842202463551.xml","form_type":"4"}},{"id":3485059,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-19","kind":"exercise","acquired":true,"shares":17404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On September 18, 2013, the Reporting Person was granted a performance-based stock option to purchase 84,000 shares of common stock under the Exelixis, Inc. 2011 Equity Incentive Plan. Vesting of the option is tied to performance goals set by the Compensation Committee (\"Committee\") as follows: (i) 50% of the option will vest if the Committee determines that top-line efficacy data received from the METEOR Phase 3 clinical trial of cabozantinib in metastatic renal cell carcinoma met its primary endpoint at a specified level, which the Committee determined had been achieved on July 20, 2015, resulting in the vesting of 50% of the option; and (ii) 50% of the option will vest if the Committee confirms the approval of cabozantinib by the U.S. Food and Drug Administration or European Medicines Agency for the treatment of metastatic castration-resistant prostate cancer, which the Committee determined could not be achieved on December 10, 2014, resulting in the forfeiture of 50% of the option."}],"balance_after":0,"derivative":{"exercise_price":5.51,"exercise_date":"2015-07-20","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":17404},"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485058,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-18","kind":"exercise","acquired":true,"shares":24596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On September 18, 2013, the Reporting Person was granted a performance-based stock option to purchase 84,000 shares of common stock under the Exelixis, Inc. 2011 Equity Incentive Plan. Vesting of the option is tied to performance goals set by the Compensation Committee (\"Committee\") as follows: (i) 50% of the option will vest if the Committee determines that top-line efficacy data received from the METEOR Phase 3 clinical trial of cabozantinib in metastatic renal cell carcinoma met its primary endpoint at a specified level, which the Committee determined had been achieved on July 20, 2015, resulting in the vesting of 50% of the option; and (ii) 50% of the option will vest if the Committee confirms the approval of cabozantinib by the U.S. Food and Drug Administration or European Medicines Agency for the treatment of metastatic castration-resistant prostate cancer, which the Committee determined could not be achieved on December 10, 2014, resulting in the forfeiture of 50% of the option."}],"balance_after":17404,"derivative":{"exercise_price":5.51,"exercise_date":"2015-07-20","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":24596},"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485057,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-18","kind":"exercise","acquired":true,"shares":75404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":320000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":75404},"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485056,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-17","kind":"exercise","acquired":true,"shares":4596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":395404,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":4596},"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485055,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-17","kind":"exercise","acquired":true,"shares":95404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, representing the right to purchase a total of 123,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016."}],"balance_after":0,"derivative":{"exercise_price":5.56,"exercise_date":"2013-09-21","expiration_date":"2019-09-20","underlying":"Common Stock","underlying_shares":95404},"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485054,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-17","kind":"sale","acquired":false,"shares":17404,"price":20.76,"value":361307.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.59 to $20.91. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4."}],"balance_after":117197,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485053,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-19","kind":"exercise","acquired":true,"shares":17404,"price":5.51,"value":95896.04,"ownership":{"direct":true},"balance_after":134601,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485052,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-18","kind":"sale","acquired":false,"shares":100000,"price":20.67,"value":2067000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.42 to $20.87. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4."}],"balance_after":117197,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485051,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-18","kind":"exercise","acquired":true,"shares":24596,"price":5.51,"value":135523.96,"ownership":{"direct":true},"balance_after":217197,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485050,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-18","kind":"exercise","acquired":true,"shares":75404,"price":1.7,"value":128186.8,"ownership":{"direct":true},"balance_after":192601,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485049,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-17","kind":"sale","acquired":false,"shares":100000,"price":20.49,"value":2049000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.29 to $20.69. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":117197,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485048,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-17","kind":"exercise","acquired":true,"shares":4596,"price":1.7,"value":7813.2,"ownership":{"direct":true},"balance_after":217197,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3485047,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-20T01:30:12.000Z","date":"2019-06-17","kind":"exercise","acquired":true,"shares":95404,"price":5.56,"value":530446.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 49,374 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":212601,"source":{"system":"sec-edgar","filing":"0000939767-19-000141","document":"wf-form4_156099419666093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000141/wf-form4_156099419666093.xml","form_type":"4"}},{"id":3490438,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2019-06-15T00:11:02.000Z","date":"2019-06-13","kind":"exercise","acquired":false,"shares":27596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 123,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016."}],"balance_after":95404,"derivative":{"exercise_price":5.56,"exercise_date":"2013-09-21","expiration_date":"2019-09-20","underlying":"Common Stock","underlying_shares":27596},"source":{"system":"sec-edgar","filing":"0000939767-19-000140","document":"wf-form4_156055744704575.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000140/wf-form4_156055744704575.xml","form_type":"4"}},{"id":3490437,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-15T00:11:02.000Z","date":"2019-06-13","kind":"sale","acquired":false,"shares":27596,"price":20.03,"value":552747.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":117197,"source":{"system":"sec-edgar","filing":"0000939767-19-000140","document":"wf-form4_156055744704575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000140/wf-form4_156055744704575.xml","form_type":"4"}},{"id":3490436,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2019-06-15T00:11:02.000Z","date":"2019-06-13","kind":"exercise","acquired":true,"shares":27596,"price":5.56,"value":153433.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 49,374 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":144793,"source":{"system":"sec-edgar","filing":"0000939767-19-000140","document":"wf-form4_156055744704575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000140/wf-form4_156055744704575.xml","form_type":"4"}},{"id":3762049,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2018-11-17T01:19:09.000Z","date":"2018-11-15","kind":"tax_withholding","acquired":false,"shares":2098,"price":17.45,"value":36610.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016."}],"balance_after":117197,"source":{"system":"sec-edgar","filing":"0000939767-18-000232","document":"wf-form4_154241753222888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000232/wf-form4_154241753222888.xml","form_type":"4"}},{"id":3762048,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2018-11-17T01:19:09.000Z","date":"2018-11-15","kind":"tax_withholding","acquired":false,"shares":7101,"price":17.45,"value":123912.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 49,374 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":119295,"source":{"system":"sec-edgar","filing":"0000939767-18-000232","document":"wf-form4_154241753222888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000232/wf-form4_154241753222888.xml","form_type":"4"}},{"id":3818829,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Option (right to buy)","published_at":"2018-09-13T00:17:00.000Z","date":"2018-09-10","kind":"grant","acquired":true,"shares":124341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Option granted will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date."}],"balance_after":124341,"derivative":{"exercise_price":18.8,"exercise_date":"2019-09-10","expiration_date":"2025-09-09","underlying":"Common Stock","underlying_shares":124341},"source":{"system":"sec-edgar","filing":"0000939767-18-000202","document":"wf-form4_153679780365221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000202/wf-form4_153679780365221.xml","form_type":"4"}},{"id":4158923,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":121550,"kind":"person","name":"Lamb Peter","position":1,"cik":"0001387306","reported_name":"Lamb Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Scientific Strategy & CSO"}}],"security":"Common Stock","published_at":"2017-11-18T00:47:50.000Z","date":"2017-11-15","kind":"tax_withholding","acquired":false,"shares":2204,"price":24.75,"value":54549.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 22, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,187 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":126396,"source":{"system":"sec-edgar","filing":"0000939767-17-000195","document":"wf-form4_151096605625450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976717000195/wf-form4_151096605625450.xml","form_type":"4"}}],"next_cursor":"2017-11-18T00:47:50.000000Z,4158923"}